In order to investigate if PPAR agonists could modulate inflammatory prostaglandins, macrophages were treated with PPAR agonists or cPLA2 antagonist before the infection to look for PG's metabolites in the conditioned media (Figure 5). This evidence concerns the gene PLA2G4A and infection.